Evidence map›Paper›PMID 37418836›Full record

ArticleESMO open2023

Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia.

L Castelo-Branco, R Lee, M Brandão, A Cortellini, A Freitas, M Garassino, T Geukens, P Grivas, S Halabi, J Oliveira and 6 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

L Castelo-BrancoScientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland; NOVA National School of Public Health, NOVA University, Lisbon, Portugal. Electronic address: luis.castelo-branco@esmo.org.
R LeeFaculty of Biology, Medicine and Health, The University of Manchester, Manchester; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK.
M BrandãoMedical Oncology Department, Institut Jules Bordet, Brussels, Belgium.
A CortelliniMedical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy; Department of Surgery and Cancer, Hammersmight Hospital Campus, Imperial College London, London.
A FreitasDepartment of Computer Science/CRUK Manchester Institute, The University of Manchester, Manchester, UK; IDIAP Research Institute, Martigny, Switzerland.
M GarassinoDepartment of medicine, Hematology Oncology section, The University of Chicago, Chicago, USA.
T GeukensLaboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
P GrivasDepartment of Medicine, Division of Oncology, University of Washington, Seattle; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle.
S HalabiDepartment of Biostatistics and Bioinformatics, Duke University, Durham, USA.
J OliveiraDepartment of Medicine, Instituto Português de Oncologia, Porto, Portugal.
D J PinatoDepartment of Surgery and Cancer, Imperial College London, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
J RibeiroGustave Roussy, Department of Cancer Medicine, Villejuif, France.
S PetersOncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
G PentheroudakisScientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland.
J L WarnerCenter for Clinical Cancer Informatics and Data Science, Division of Hematology/Oncology, Department of Medicine, Brown University, Providence, USA.
E RomanoEmanuela Romano Center of Cancer Immunotherapy, Department of Oncology, Institut Curie, Paris, France.

Funding

Wellcome Trust 225724
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansMedical OncologyPandemicsSARS-CoV-2

Identifiers

PMID37418836
PMCPMC10277850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.